Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|8|704-723

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.8, 2009-05, pp. : 704-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4725-4746

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Rho-kinase inhibitors show promise in pulmonary hypertension

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1157-1159

Informa Healthcare

Access to resources Recommend Favorite

The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction

By  

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 660-666

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to the Treatment of Inflammatory Disorders Small Molecule inhibitors of p38 MAP Kinase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. : 113-149

Bentham Science Publishers

Access to resources Recommend Favorite